You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昊海生物科技(06826.HK)業績快報:2023年歸母淨利4.16億元 同比增長130.58%
格隆匯 02-23 17:54

格隆匯2月23日丨昊海生物科技(06826.HK)發佈2023年度業績快報,報吿期內,集團實現營業收入人民幣26.54億元,同比增長24.59%;實現歸屬於母公司股東的淨利潤人民幣4.16億元,同比增長130.58%;實現歸屬於母公司股東的扣除非經常性損益的淨利潤人民幣3.83億元,同比增長141.52%。

公司和位於上海地區的生產型子公司在2022年3月至5月期間生產經營停滯,以及2022年對美國子公司Aaren Scientific Inc.業務的商譽及無形資產計提的資產減值損失,都對集團2022年的營業收入及利潤產生重大不利影響。報吿期內,隨着外部經營環境的穩定,集團生產經營銷售情況平穩恢復並持續向好,各產品線尤其是玻尿酸產品的銷量、收入與上年同期相比均有顯著增長。

報吿期內,集團營業利潤較上年增長116.30%,利潤總額較上年增長115.61%,歸屬於母公司股東的淨利潤較上年增長130.58%,歸屬於母公司股東的扣除非經常性損益的淨利潤較上年增長141.52%,主要是由於報吿期內高毛利玻尿酸產品收入的大幅增長所帶來的營業利潤和淨利潤的增長,以及上述提到的2022年的生產經營停滯和資產減值損失的事件在報吿期內未有發生的雙重影響所致。報吿期內,公司基本每股收益較上年增長134.62%,主要是歸屬於母公司股東的淨利潤增長所致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account